APA (7th ed.) Citation

Shetty, C. R., Shastry, C. S., P., P., & Hebbar, S. (2024). Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines. BioImpacts, 14(4), 1. https://doi.org/10.34172/bi.2023.29951

Chicago Style (17th ed.) Citation

Shetty, Chaithra R., C. S. Shastry, Parasuraman P., and Srinivas Hebbar. "Thiazolo-pyridopyrimidines: An in Silico Evaluation as a Lead for CDK4/6 Inhibition, Synthesis and Cytotoxicity Screening Against Breast Cancer Cell Lines." BioImpacts 14, no. 4 (2024): 1. https://doi.org/10.34172/bi.2023.29951.

MLA (9th ed.) Citation

Shetty, Chaithra R., et al. "Thiazolo-pyridopyrimidines: An in Silico Evaluation as a Lead for CDK4/6 Inhibition, Synthesis and Cytotoxicity Screening Against Breast Cancer Cell Lines." BioImpacts, vol. 14, no. 4, 2024, p. 1, https://doi.org/10.34172/bi.2023.29951.